LifeArc invests in Cumulus Neuroscience
Investment part of £6 million funding round led by Dementia Discovery Fund, supported by UK Future Fund
Investment part of £6 million funding round led by Dementia Discovery Fund, supported by UK Future Fund
LifeArc announces Seed Fund investment of £2 million in DJS Antibodies, a biotech start-up company pioneering the…
Funding to help drive the development of new cancer therapies
Investment to allow Caldan to translate work on free fatty acid receptors initiated in their laboratories
LifeArc’s Seed Fund has invested £1.5 million in Ducentis BioTherapeutics to develop novel drug therapies for inflammatory and autoimmune disease